Echomedic: Difference between revisions
Created from NHT member research |
Created with researched data |
||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:Echomedic}} | ||
|name=Echomedic | {{Infobox company | ||
| | | name = Echomedic AS | ||
| | | org_number = 935870631 | ||
| | | founded = 2025-06-25 | ||
|funding= | | employees = Not disclosed | ||
| | | address = Norway | ||
| industry = 62.100 – Computer programming | |||
| website = Not publicly available | |||
| nht_category = Startup | |||
| description = Echomedic AS was registered in June 2025 — extremely recent. No public product or service information available. Very early-stage company. | |||
| notes = Founded June 2025 — most recent company on this list. No website, no product info. No disclosed revenue or funding. | |||
| related_companies = [[Norway Health Tech]] | |||
| categories = Norway Health Tech, Startups | |||
| sources = https://data.brreg.no/enhetsregisteret/api/enheter/935870631 | |||
}} | }} | ||
== | == About == | ||
Echomedic AS is a Norwegian health technology company registered in June 2025, making it one of the most recently established companies in the Norway Health Tech cluster. No public product or business information was available at time of research. | |||
== | == Research Status == | ||
Given the very recent founding date (June 2025), the company may not yet have a public web presence or product offering. Further monitoring is recommended. | |||
[[Category: | == References == | ||
[[Category: | <references/> | ||
[[Category:Norway Health Tech]] | |||
[[Category:Startups]] | |||
Latest revision as of 20:01, 14 April 2026
About[edit]
Echomedic AS is a Norwegian health technology company registered in June 2025, making it one of the most recently established companies in the Norway Health Tech cluster. No public product or business information was available at time of research.
Research Status[edit]
Given the very recent founding date (June 2025), the company may not yet have a public web presence or product offering. Further monitoring is recommended.